1. Home
  2. SVRA vs GCI Comparison

SVRA vs GCI Comparison

Compare SVRA & GCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • GCI
  • Stock Information
  • Founded
  • SVRA 2007
  • GCI 1997
  • Country
  • SVRA United States
  • GCI United States
  • Employees
  • SVRA N/A
  • GCI N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • GCI Newspapers/Magazines
  • Sector
  • SVRA Health Care
  • GCI Consumer Discretionary
  • Exchange
  • SVRA Nasdaq
  • GCI Nasdaq
  • Market Cap
  • SVRA 505.8M
  • GCI 549.7M
  • IPO Year
  • SVRA N/A
  • GCI N/A
  • Fundamental
  • Price
  • SVRA $3.00
  • GCI $3.15
  • Analyst Decision
  • SVRA Buy
  • GCI Buy
  • Analyst Count
  • SVRA 6
  • GCI 3
  • Target Price
  • SVRA $8.83
  • GCI $5.70
  • AVG Volume (30 Days)
  • SVRA 615.8K
  • GCI 2.0M
  • Earning Date
  • SVRA 05-16-2025
  • GCI 05-01-2025
  • Dividend Yield
  • SVRA N/A
  • GCI N/A
  • EPS Growth
  • SVRA N/A
  • GCI N/A
  • EPS
  • SVRA N/A
  • GCI 0.36
  • Revenue
  • SVRA N/A
  • GCI $2,445,127,000.00
  • Revenue This Year
  • SVRA N/A
  • GCI N/A
  • Revenue Next Year
  • SVRA N/A
  • GCI N/A
  • P/E Ratio
  • SVRA N/A
  • GCI $8.86
  • Revenue Growth
  • SVRA N/A
  • GCI N/A
  • 52 Week Low
  • SVRA $2.26
  • GCI $2.55
  • 52 Week High
  • SVRA $5.31
  • GCI $5.93
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 47.98
  • GCI 47.04
  • Support Level
  • SVRA $3.12
  • GCI $3.08
  • Resistance Level
  • SVRA $3.56
  • GCI $3.32
  • Average True Range (ATR)
  • SVRA 0.15
  • GCI 0.22
  • MACD
  • SVRA -0.01
  • GCI 0.00
  • Stochastic Oscillator
  • SVRA 21.19
  • GCI 31.18

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About GCI Gannett Co. Inc.

Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.

Share on Social Networks: